What is the main product of a cod?
That was the question Line Kjelstrup of Biotech North brought to Torskefisk 2026 in Tromsø, where the Norwegian Seafood Council gathered the whitefish industry to discuss competition at a time of low quotas. Our CEO Andreas Lyhammer joined her on stage with Svein Egil Stavem of Orkla Health Ocean and Magnus Stoud Myhre of SINTEF Ocean.
The Norwegian industry has come a long way. SINTEF Ocean’s figures show that 72% of the available residual raw material from whitefish is now used, and Line pointed out that in some cases the side streams already earn more than the fillet.
Iceland’s experience shows where that step can lead. When quotas were introduced in the 1980s after a sharp drop in the cod stock, the industry there set out to get more value from every fish, and over time that focus gave rise to companies such as Zymetech and Kerecis.
Figures from the Iceland Ocean Cluster show that a cod once worth around $12 can generate more than $6,000 when every part is used. The Norwegian whitefish industry is well placed to create that value here, and Havdis is part of that wave, building on cod milt, one of the least used parts of the catch. Less fish does not have to mean less value.
Thank you to Line Kjelstrup and Biotech North for leading the discussion and to the Norwegian Seafood Council and Tove Sleipnes for hosting.
#Torskefiskkonferansen #Restråstoff #BlueEconomy
Lalit Rane, Benedek Regoczi, Silje Kristiane Reed Aasgaard, Rasmus August Engh Tønnessen, Rebecca Eriksson, Sunil Kumar Pandey, MSc, PhD., Deepti Patil, Thor Sigfusson PhD, Hege Hammersland, Ragnar Thorisson, Bjarni Markusson, Torleif Markussen Lunde, Claus Gladyszak, FORREGION Vestland, Innovation Norway


Originally posted on LinkedIn on 8 November 2026. See the post on LinkedIn